---
schema_version: "secwatch.filing_event.v1"
accession: "0001129928-26-000039"
form_type: "8-K"
ticker: "ONCY"
cik: "0001129928"
company_name: "ONCOLYTICS BIOTECH INC"
filed_at: "2026-06-02T13:02:48+00:00"
generated_at: "2026-06-02T13:04:11.303359+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oncolytics appoints Steve Glover to board, promotes John McAdory to COO

## Summary
- Steve Glover appointed to board effective June 1, 2026; he chaired Ambrx during its $2B J&J acquisition.
- John McAdory promoted to COO effective June 1, 2026; previously EVP Strategy & Operations since Jan 2026.
- McAdory will oversee clinical ops, preclinical R&D, strategic partnerships, and business development.
- Glover receives an option to purchase 96,000 shares vesting over three years; McAdory receives no extra compensation.
- Glover brings 35+ years biopharma experience; also chairs ZyVersa Therapeutics and sits on PDS Biotech board.

## SEC filing metadata
- accession: 0001129928-26-000039
- form_type: 8-K
- ticker: ONCY
- cik: 0001129928
- company_name: ONCOLYTICS BIOTECH INC
- filed_at: 2026-06-02T13:02:48+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/0001129928-26-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/oncy-20260602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001129928-26-000039
- JSON: https://secwatch.observer/filing/0001129928-26-000039.json
- Plain text: https://secwatch.observer/filing/0001129928-26-000039.txt

## Source-grounded claims
- claim_id: 51d737ca37
  claim: John McAdory was appointed as Chief Operating Officer at ONCOLYTICS BIOTECH INC.
  evidence_excerpt: appointed John McAdory as Chief Operating Officer of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/0001129928-26-000039-index.htm
- claim_id: 899e3fdee0
  claim: Stephen Glover was appointed as Director at ONCOLYTICS BIOTECH INC.
  evidence_excerpt: appointed Stephen Glover as the ninth director of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/0001129928-26-000039-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.